>
>
First patient surgery completed; additional surgeries already scheduled 8 clinical centres now fully initiated and recruiting / screening for patients MONTREAL, July 27, 2022 /PRNewswire/
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL
ortho regenerative technologies reports its first quarter 2023 results ortho regenerative technologies reports its first quarter 2023 results canada newswire montreal june 24 2022 patients
Contracting procedures completed for 6 of the 10 clinical trial sites 5 sites fully activated, with ongoing patients’ screening and recruitment MONTREAL, June 13, 2022
Meniscus indication confirms proprietary technology platform multi-indications potential Grant to accelerate development of second clinical indication MONTREAL, May 26, 2022 /PRNewswire/ – Ortho Regenerative Technologies
ortho regenerative technologies reports its fourth quarter and 2022 year end results ortho regenerative technologies reports its fourth quarter and 2022 year end results canada
New patent issued by U.S. Patent and Trademark Office to protect core IP until 2035 Positions Company as leading player in the dynamic regenerative medicine
MONTREAL, March 24, 2022 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (“Ortho” or the “Company“), a clinical-stage orthobiologics company focused on the development
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES Canada NewsWire MONTREAL, March 15, 2022 Philippe Deschamps appointed President and
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES Canada NewsWire MONTREAL, March 15, 2022 Philippe Deschamps appointed President and
